Stay updated on Ribociclib and Trametinib in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Ribociclib and Trametinib in Solid Tumors Clinical Trial page.

Latest updates to the Ribociclib and Trametinib in Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded an NIH grant/contract year to the study identifiers and updated the site revision from v3.6.5 to v3.6.6, reflecting lightweight metadata changes.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5 on the page, indicating a newer revision of the study record without altering its content.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a software/content update to the page, rather than a change to the study details.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, signaling a new site release for the ClinicalTrials.gov page. This update reflects maintenance or improvements to the site and does not alter the study data or presented content.SummaryDifference0.0%

- Check76 days agoChange DetectedA newer revision stamp 'Revision: v3.6.2' appears on the page, replacing the previous 'Revision: v3.6.0', indicating an updated version of the page. This change reflects a backend or content update and does not alter the study data or outcomes.SummaryDifference0.0%

- Check91 days agoChange DetectedRecruitment status is updated to no longer look for participants. New guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) are added to improve navigation and enrollment, and the page's Intervention/Treatment header formatting plus a revision stamp to v3.6.0 are updated.SummaryDifference0.5%

Stay in the know with updates to Ribociclib and Trametinib in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ribociclib and Trametinib in Solid Tumors Clinical Trial page.